[{"id":"bfed7cb6-f069-4679-bb0b-bd2b8bfbcd9b","acronym":"SHR-4602-I-101","url":"https://clinicaltrials.gov/study/NCT05819684","created_at":"2023-04-19T19:07:13.683Z","updated_at":"2024-07-02T16:35:47.737Z","phase":"Phase 1","brief_title":"A Study of SHR-4602 in Subjects With Advanced Malignant Solid Tumors","source_id_and_acronym":"NCT05819684 - SHR-4602-I-101","lead_sponsor":"Suzhou Suncadia Biopharmaceuticals Co., Ltd.","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 mutation • HER-2 expression","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 mutation • HER-2 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SHR-4602"],"overall_status":"Recruiting","enrollment":" Enrollment 133","initiation":"Initiation: 05/06/2023","start_date":" 05/06/2023","primary_txt":" Primary completion: 05/30/2025","primary_completion_date":" 05/30/2025","study_txt":" Completion: 05/30/2026","study_completion_date":" 05/30/2026","last_update_posted":"2023-05-17"}]